Report: Deception in clinical trials ‘squanders precious research resources’
Deception among clinical research participants is prevalent and a global issue, say researchers, with self-reported adherence found to be largely inaccurate.
Archives for September 21, 2018
FDA extends the scope of opioid REMS to include IR and education
The FDA has approved an updated opioid analgesics risk evaluation and mitigation strategy, including measures that apply to immediate-release opioids.
Siga signs $629m contract with BARDA for smallpox drug stockpiling
Siga signed a multiyear contract with BARDA for the delivery of oral and IV formulations of TPOXX to the Strategic National Stockpile.
Infographic: Breaking down antimicrobial resistance
The topic of antimicrobial resistance is back in the spotlight after the US FDA released a new website and a number of proposals to encourage the drug development in the area.
Switzerland to Canada: GSK transfers Voltaren tech for local supply
GSK has invested $27.8m into manufacturing operations in Canada, including a technology transfer of Voltaren products from facilities in Switzerland to Mississauga.